Frederic Schaper, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 10 | 2023 | 829 | 1.520 |
Why?
|
| Interleukin-6 | 22 | 2021 | 3210 | 1.310 |
Why?
|
| Anterior Thalamic Nuclei | 3 | 2023 | 27 | 1.030 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2021 | 133 | 0.730 |
Why?
|
| Genes, fos | 1 | 2021 | 175 | 0.720 |
Why?
|
| Neurites | 1 | 2021 | 391 | 0.630 |
Why?
|
| Protein Tyrosine Phosphatases | 7 | 2001 | 456 | 0.540 |
Why?
|
| HMGB1 Protein | 1 | 2017 | 136 | 0.510 |
Why?
|
| Antibodies, Antinuclear | 1 | 2017 | 342 | 0.500 |
Why?
|
| Epilepsy | 4 | 2023 | 3304 | 0.490 |
Why?
|
| STAT3 Transcription Factor | 13 | 2022 | 872 | 0.480 |
Why?
|
| Neurogenesis | 1 | 2021 | 862 | 0.460 |
Why?
|
| Subthalamic Nucleus | 3 | 2022 | 194 | 0.430 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 7 | 2021 | 223 | 0.390 |
Why?
|
| Membrane Glycoproteins | 13 | 2001 | 3696 | 0.390 |
Why?
|
| Antigens, CD | 13 | 2001 | 4009 | 0.380 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2159 | 0.370 |
Why?
|
| Cytokine Receptor gp130 | 13 | 2021 | 66 | 0.370 |
Why?
|
| Neural Pathways | 2 | 2021 | 3056 | 0.350 |
Why?
|
| Trans-Activators | 15 | 2001 | 2846 | 0.310 |
Why?
|
| Cytoplasm | 4 | 2000 | 1498 | 0.280 |
Why?
|
| Repressor Proteins | 6 | 2001 | 2974 | 0.250 |
Why?
|
| Tyrosine | 5 | 2000 | 1422 | 0.250 |
Why?
|
| Signal Transduction | 18 | 2022 | 23416 | 0.250 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 4537 | 0.240 |
Why?
|
| alpha-Macroglobulins | 2 | 2001 | 60 | 0.240 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 2157 | 0.230 |
Why?
|
| Stroke | 2 | 2023 | 9721 | 0.230 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 6 | 2001 | 120 | 0.230 |
Why?
|
| Growth Inhibitors | 3 | 2000 | 374 | 0.210 |
Why?
|
| Transcriptional Activation | 6 | 2022 | 1749 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2001 | 2871 | 0.200 |
Why?
|
| Seizures | 4 | 2023 | 2965 | 0.200 |
Why?
|
| Proteins | 7 | 2001 | 5993 | 0.180 |
Why?
|
| DNA-Binding Proteins | 15 | 2001 | 9566 | 0.180 |
Why?
|
| Hormone Antagonists | 1 | 2021 | 107 | 0.180 |
Why?
|
| PC12 Cells | 1 | 2021 | 317 | 0.180 |
Why?
|
| STAT1 Transcription Factor | 8 | 2022 | 340 | 0.170 |
Why?
|
| Tinnitus | 1 | 2023 | 196 | 0.170 |
Why?
|
| Mifepristone | 1 | 2021 | 151 | 0.170 |
Why?
|
| Epilepsies, Partial | 1 | 2023 | 431 | 0.160 |
Why?
|
| Ventral Tegmental Area | 1 | 2020 | 132 | 0.160 |
Why?
|
| Mental Disorders | 4 | 2023 | 6823 | 0.160 |
Why?
|
| Lymphokines | 3 | 2000 | 925 | 0.160 |
Why?
|
| Thalamus | 3 | 2022 | 1046 | 0.160 |
Why?
|
| Neurons | 1 | 2018 | 9428 | 0.160 |
Why?
|
| Transcription Factors | 7 | 2001 | 12099 | 0.150 |
Why?
|
| Cell Division | 3 | 2001 | 4451 | 0.150 |
Why?
|
| Interleukin-1 | 1 | 2001 | 1250 | 0.140 |
Why?
|
| Parkinson Disease | 2 | 2022 | 2867 | 0.140 |
Why?
|
| Glutamate Decarboxylase | 1 | 2018 | 239 | 0.140 |
Why?
|
| Microelectrodes | 1 | 2018 | 306 | 0.140 |
Why?
|
| Spirituality | 1 | 2021 | 429 | 0.130 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 3 | 2000 | 43 | 0.130 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 6 | 2001 | 178 | 0.130 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2023 | 1473 | 0.130 |
Why?
|
| Rats, Transgenic | 2 | 2012 | 69 | 0.130 |
Why?
|
| Receptors, Cytokine | 4 | 2000 | 257 | 0.130 |
Why?
|
| Nerve Net | 2 | 2024 | 2288 | 0.130 |
Why?
|
| Caudate Nucleus | 1 | 2016 | 390 | 0.120 |
Why?
|
| Complement C3 | 1 | 2017 | 434 | 0.120 |
Why?
|
| Sjogren's Syndrome | 1 | 2017 | 238 | 0.120 |
Why?
|
| Huntington Disease | 2 | 2012 | 1145 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2024 | 22174 | 0.120 |
Why?
|
| Brain | 9 | 2024 | 27092 | 0.120 |
Why?
|
| Cerebral Cortex | 5 | 2023 | 5775 | 0.120 |
Why?
|
| src Homology Domains | 3 | 2000 | 361 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 6 | 2001 | 6124 | 0.110 |
Why?
|
| Brain Injuries | 2 | 2024 | 2054 | 0.110 |
Why?
|
| Receptors, Interleukin-6 | 5 | 2021 | 224 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2021 | 1945 | 0.110 |
Why?
|
| Rats | 6 | 2021 | 23704 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2001 | 2475 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2021 | 2925 | 0.100 |
Why?
|
| Phosphorylation | 5 | 2021 | 8300 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2001 | 3726 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2000 | 1681 | 0.100 |
Why?
|
| Electrodes, Implanted | 1 | 2016 | 839 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2022 | 1513 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2001 | 1240 | 0.100 |
Why?
|
| Humans | 43 | 2024 | 761208 | 0.090 |
Why?
|
| Cell Survival | 1 | 2021 | 5778 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2021 | 1663 | 0.090 |
Why?
|
| Health Services for the Aged | 1 | 2012 | 258 | 0.090 |
Why?
|
| Dimerization | 3 | 2000 | 887 | 0.090 |
Why?
|
| Electroencephalography | 5 | 2023 | 6242 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3803 | 0.080 |
Why?
|
| Religion | 2 | 2024 | 376 | 0.080 |
Why?
|
| Community Mental Health Services | 1 | 2012 | 387 | 0.080 |
Why?
|
| Amino Acid Motifs | 3 | 2000 | 924 | 0.080 |
Why?
|
| Precipitin Tests | 2 | 2000 | 812 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2018 | 2119 | 0.080 |
Why?
|
| Peptides | 2 | 2000 | 4353 | 0.080 |
Why?
|
| Protein Phosphatase 2 | 2 | 2001 | 231 | 0.080 |
Why?
|
| Rural Health Services | 1 | 2012 | 384 | 0.080 |
Why?
|
| Male | 16 | 2024 | 360693 | 0.080 |
Why?
|
| Adult | 11 | 2024 | 221119 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2001 | 4744 | 0.080 |
Why?
|
| Cytokines | 3 | 2000 | 7386 | 0.080 |
Why?
|
| Gene Expression Regulation | 11 | 2022 | 11856 | 0.080 |
Why?
|
| Middle Aged | 10 | 2024 | 220853 | 0.070 |
Why?
|
| Enzyme Activation | 4 | 2001 | 3577 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2000 | 2426 | 0.070 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 3 | 2000 | 30 | 0.070 |
Why?
|
| Receptors, OSM-LIF | 3 | 2000 | 15 | 0.070 |
Why?
|
| Female | 12 | 2024 | 392544 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1998 | 4513 | 0.070 |
Why?
|
| Animals | 19 | 2021 | 168079 | 0.070 |
Why?
|
| Leukemia Inhibitory Factor | 3 | 2000 | 77 | 0.070 |
Why?
|
| Neuropsychological Tests | 2 | 2016 | 7046 | 0.070 |
Why?
|
| Young Adult | 4 | 2024 | 59221 | 0.060 |
Why?
|
| Transfection | 4 | 2000 | 5748 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10422 | 0.060 |
Why?
|
| Endocytosis | 2 | 1999 | 950 | 0.060 |
Why?
|
| Base Sequence | 5 | 2001 | 12404 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2011 | 1198 | 0.060 |
Why?
|
| Receptors, Oncostatin M | 2 | 2000 | 2 | 0.060 |
Why?
|
| Aged | 9 | 2024 | 169288 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 17598 | 0.060 |
Why?
|
| Oncostatin M | 2 | 2000 | 42 | 0.060 |
Why?
|
| Disabled Persons | 1 | 2012 | 1224 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2011 | 5782 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2000 | 818 | 0.050 |
Why?
|
| Acute-Phase Proteins | 2 | 2000 | 250 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 4404 | 0.050 |
Why?
|
| Janus Kinase 1 | 2 | 2000 | 107 | 0.050 |
Why?
|
| Inflammation | 1 | 2021 | 10759 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18220 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 3753 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2001 | 5773 | 0.050 |
Why?
|
| COS Cells | 2 | 2000 | 1129 | 0.050 |
Why?
|
| Rats, Wistar | 2 | 2001 | 1848 | 0.040 |
Why?
|
| Janus Kinases | 1 | 2021 | 248 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2001 | 489 | 0.040 |
Why?
|
| STAT2 Transcription Factor | 1 | 1999 | 27 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2001 | 1140 | 0.040 |
Why?
|
| Cell Line | 7 | 2001 | 15545 | 0.040 |
Why?
|
| Liver Regeneration | 1 | 2001 | 214 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2023 | 64681 | 0.040 |
Why?
|
| Body Image | 1 | 2024 | 639 | 0.040 |
Why?
|
| Isoleucine | 1 | 1999 | 110 | 0.040 |
Why?
|
| Depression | 1 | 2019 | 8132 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2001 | 4340 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15841 | 0.040 |
Why?
|
| TYK2 Kinase | 1 | 1998 | 38 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2001 | 2293 | 0.040 |
Why?
|
| Sleep Stages | 1 | 2022 | 695 | 0.040 |
Why?
|
| Half-Life | 1 | 1999 | 649 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 2000 | 1545 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2023 | 1736 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 2023 | 852 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2000 | 564 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2000 | 819 | 0.040 |
Why?
|
| Atrophy | 1 | 2023 | 1633 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 275 | 0.040 |
Why?
|
| Leucine | 1 | 1999 | 546 | 0.040 |
Why?
|
| Comorbidity | 3 | 2023 | 10516 | 0.040 |
Why?
|
| Postprandial Period | 1 | 1999 | 314 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2023 | 1047 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2000 | 4935 | 0.040 |
Why?
|
| Cell Nucleus | 3 | 2001 | 2881 | 0.030 |
Why?
|
| Tunica Intima | 1 | 1999 | 458 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2000 | 1644 | 0.030 |
Why?
|
| Sleep | 2 | 2022 | 4759 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 2023 | 1114 | 0.030 |
Why?
|
| Consciousness | 1 | 2022 | 601 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 36415 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2000 | 1518 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 1998 | 559 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2001 | 1408 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2024 | 80674 | 0.030 |
Why?
|
| Kinetics | 2 | 2000 | 6312 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 1999 | 941 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 8164 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2018 | 54435 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1651 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 2091 | 0.030 |
Why?
|
| Adolescent | 3 | 2018 | 88298 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 22140 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 2000 | 4309 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2000 | 3661 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2000 | 1480 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2001 | 3155 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2023 | 5250 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2001 | 4111 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 1999 | 2199 | 0.020 |
Why?
|
| Executive Function | 1 | 2020 | 1388 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2022 | 7571 | 0.020 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2012 | 114 | 0.020 |
Why?
|
| Community-Institutional Relations | 1 | 2012 | 206 | 0.020 |
Why?
|
| Protein Binding | 2 | 2000 | 9297 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2022 | 12747 | 0.020 |
Why?
|
| Patient Advocacy | 1 | 2012 | 358 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2012 | 781 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2000 | 3388 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2022 | 2787 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 6504 | 0.020 |
Why?
|
| Receptors, Interleukin | 2 | 2001 | 242 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2012 | 634 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2012 | 544 | 0.020 |
Why?
|
| Australia | 1 | 2012 | 1246 | 0.020 |
Why?
|
| Nervous System | 1 | 2012 | 545 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2012 | 1989 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2016 | 1880 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 13402 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2001 | 680 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2000 | 5103 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 30002 | 0.020 |
Why?
|
| Pain | 1 | 2021 | 5072 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 39126 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1506 | 0.020 |
Why?
|
| DNA Primers | 2 | 2000 | 2814 | 0.020 |
Why?
|
| Macrophages | 1 | 1999 | 5753 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1999 | 5921 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1999 | 6392 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2012 | 1873 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 4767 | 0.010 |
Why?
|
| Mice | 5 | 2001 | 81326 | 0.010 |
Why?
|
| Cognition | 1 | 2020 | 6988 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 9187 | 0.010 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2001 | 20 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1998 | 7851 | 0.010 |
Why?
|
| Receptors, Interleukin-11 | 1 | 2001 | 1 | 0.010 |
Why?
|
| Receptors, Erythropoietin | 1 | 2001 | 144 | 0.010 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2001 | 14 | 0.010 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 1 | 2001 | 36 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 2001 | 115 | 0.010 |
Why?
|
| Melanoma | 1 | 2000 | 5694 | 0.010 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2001 | 110 | 0.010 |
Why?
|
| Prognosis | 1 | 2022 | 29687 | 0.010 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2000 | 30 | 0.010 |
Why?
|
| Receptors, Interleukin-5 | 1 | 2000 | 20 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58952 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 255 | 0.010 |
Why?
|
| Genes, Suppressor | 1 | 1999 | 47 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 2000 | 266 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2000 | 459 | 0.010 |
Why?
|
| Kupffer Cells | 1 | 1999 | 143 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8642 | 0.010 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 1998 | 23 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 438 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2000 | 704 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2001 | 585 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2001 | 515 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2000 | 575 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 588 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 1429 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 551 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2000 | 725 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2001 | 557 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 665 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2001 | 1435 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1998 | 303 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1999 | 1178 | 0.010 |
Why?
|
| Imidazoles | 1 | 2001 | 1172 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41496 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 42224 | 0.010 |
Why?
|
| Age Factors | 1 | 2011 | 18384 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16575 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2001 | 1318 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 2854 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1999 | 2928 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1999 | 2635 | 0.010 |
Why?
|
| Binding Sites | 1 | 2000 | 5988 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3702 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1998 | 3933 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1999 | 6223 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2000 | 2667 | 0.010 |
Why?
|
| Child | 1 | 2018 | 80152 | 0.010 |
Why?
|
| Pyridines | 1 | 2001 | 2872 | 0.010 |
Why?
|
| Health Surveys | 1 | 1999 | 4037 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1999 | 5871 | 0.000 |
Why?
|
| Models, Molecular | 1 | 1998 | 5406 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 9520 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1999 | 5969 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 2001 | 14392 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2000 | 18926 | 0.000 |
Why?
|
| Liver | 1 | 1999 | 7514 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2000 | 10203 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1998 | 11509 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1999 | 5842 | 0.000 |
Why?
|
| Risk Assessment | 1 | 1999 | 24021 | 0.000 |
Why?
|
| Risk Factors | 1 | 1999 | 74239 | 0.000 |
Why?
|